Compare Humana Inc (HUM) vs SOLAI Limited (SLAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs SOLAI Limited — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: Humana Inc is far larger — about 2774.7× SOLAI Limited's market cap, and Humana Inc pays a 0.92% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals.
| HUM | SLAI | |
|---|---|---|
Market Cap | $46.31B | $16.69M |
Sector | Health | Technology |
52-Week High | $409.42 | $26.74 |
52-Week Low | $163.67 | $2.74 |
Enterprise Value | $53.67B | $16.33M |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
SLAI trades at $3.72 with no recent price movement. The company faces severe financial distress with negative gross and net income margins, substantial losses, and a recent delisting notice from the NYSE. Technical indicators show a bullish signal despite fundamental weakness, while the sole analyst coverage maintains a hold rating. Recent corporate actions include a reverse stock split and acquisition activity.
The outlook remains highly speculative with significant execution and regulatory risks. Investment opportunity exists only for risk-tolerant investors betting on the company's AI infrastructure pivot, but current financials and delisting proceedings present substantial downside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
